Related Experiment Video
Updated: Jul 31, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia
Yacui Wang1,2,3, Xiaoran Yu1,4, Fang Liu1,2
1Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Children's Health, Beijing, People's Republic of China.
Abstract:
Although previous studies have reported the dysregulation of respiratory tract microbiota in infectious diseases, insufficient data exist regarding respiratory microbiota imbalances in the lower respiratory tracts (LRTs) of children with Mycoplasma pneumoniae pneumonia (MPP). Here, we analysed the microbial community using 16S rRNA gene sequencing. Finally, bronchoalveolar lavage fluid (BALF) samples from 158 children with MPP and 29 with bacterial or viral pneumonia (control group) were collected. The diversity of the microbial community was significantly different between the two groups. A significantly increased abundance of Tenericutes and Mycoplasma was detected in the MPP group, exceeding 67% and 65% of the total bacterial population, respectively. Using Mycoplasma abundance as the diagnostic method, the sensitivity and specificity of the model was 97.5% and 96.6%, respectively. Compared to the mild MPP group, lower alpha diversity and significantly increased Mycoplasma abundance were found in the severe MPP group (P < 0.01). The abundance of Mycoplasma was positively correlated with complications and clinical indices in children with severe MPP compared with children with mild MPP. Our study describes the features of the LRT microbiota of children with MPP and uncovered its association with disease severity. This finding may offer insights into the pathogenesis of MPP in children.
Insights
Researchers analyzed lower respiratory tract (LRT) microbiota in children with Mycoplasma pneumoniae pneumonia (MPP). They found increased Mycoplasma abundance, which correlated with disease severity and complications, offering insights into MPP pathogenesis.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Pulmonology
Background:
- Dysregulation of respiratory tract microbiota is implicated in infectious diseases.
- Limited data exist on lower respiratory tract (LRT) microbiota in pediatric Mycoplasma pneumoniae pneumonia (MPP).
Purpose of the Study:
- To characterize the LRT microbiota in children with MPP.
- To investigate the association between LRT microbiota and MPP severity.
Main Methods:
- 16S rRNA gene sequencing was used to analyze bronchoalveolar lavage fluid (BALF) samples.
- 158 children with MPP and 29 controls (bacterial/viral pneumonia) were studied.
Main Results:
- Significant differences in microbial community diversity were observed between MPP and control groups.
- Increased abundance of Tenericutes and Mycoplasma (exceeding 67% and 65% respectively) was found in the MPP group.
- Mycoplasma abundance showed high diagnostic accuracy (97.5% sensitivity, 96.6% specificity) and correlated with disease severity and complications.
Conclusions:
- LRT microbiota in children with MPP is characterized by increased Mycoplasma abundance.
- Mycoplasma abundance is linked to MPP severity and clinical outcomes in children.
- Findings provide insights into the pathogenesis of pediatric MPP.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-III
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...

